FAM
JBIO
Fred Alger Management’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-43,790
| Closed | -$1.29M | – | 431 |
|
|
2024
Q1 | $1.29M | Buy |
43,790
+7,312
| +20% | +$216K | 0.01% | 362 |
|
|
2023
Q4 | $825K | Buy |
36,478
+11,731
| +47% | +$265K | ﹤0.01% | 374 |
|
|
2023
Q3 | $336K | Sell |
24,747
-33,127
| -57% | -$450K | ﹤0.01% | 394 |
|
|
2023
Q2 | $993K | Sell |
57,874
-46,174
| -44% | -$792K | 0.01% | 379 |
|
|
2023
Q1 | $2.1M | Sell |
104,048
-43,907
| -30% | -$885K | 0.01% | 342 |
|
|
2022
Q4 | $4.34M | Sell |
147,955
-34,326
| -19% | -$1.01M | 0.02% | 276 |
|
|
2022
Q3 | $3.02M | Buy |
182,281
+9,575
| +6% | +$159K | 0.02% | 300 |
|
|
2022
Q2 | $2.7M | Buy |
172,706
+5,699
| +3% | +$88.6K | 0.01% | 319 |
|
|
2022
Q1 | $3.06M | Hold |
167,007
| – | – | 0.01% | 312 |
|
|
2021
Q4 | $1.97M | Buy |
+167,007
| New | +$1.97M | ﹤0.01% | 356 |
|